- Merz launches new athlete's foot gel strength
- At least 23,000 die from antibiotic-resistant infections each year, CDC finds
- Chickenpox vaccine does not appear to increase incidence of shingles, study finds
- Study: Pharmacist intervention improves shingles vaccine rate
- Study: Whooping cough vaccine may not prevent infection
ST. PAUL, Minn. — 3M's skin and wound care division has launched an easy-to-apply cream that is designed to relieve skin discomforts caused by fungal infections.
New Cavilon antifungal cream, which is available in 2-oz. and 5-oz. tubes, is enriched with water-repelling ingredients, including 2% miconazole nitrate, an active ingredient that has been clinically proven to treat tinea corporis (ringworm), tinea pedis (athlete’s foot) and tinea cruris (jock itch), 3M said. The product also is approved for use on fungal infections caused by Candida albicans.
“Cavilon antifungal cream fills a significant need for clinicians and their patients, and by launching this new product, 3M is reinforcing its strong commitment to skin care,” said Marcello Napol, global business director of 3M skin and wound care. “It also bolsters our Cavilon brand by meeting clinical needs for all types of skin applications.”